BIO-TECHNE CORP (TECH)
US09073M1045 - Common Stock
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 224.16M | 285.40M | 263.10M | 139.60M | 229.30M | |||
| Depreciation Amortization | 110.24M | 107.20M | 101.10M | 87.70M | 82.70M | |||
| Income Taxes - Deferred | -45.51M | -29.60M | 6.80M | -27.40M | 13.10M | |||
| Change In Working Capital | -51.50M | -90.60M | -69.50M | 29.30M | -5.20M | |||
| Interest Paid | 11.39M | 8.40M | 11.00M | 13.60M | 18.60M | |||
| Taxes Paid | 99.64M | 88.40M | 30.30M | 21.00M | 42.00M | |||
| Other non cash items | 39.01M | -18.10M | 23.80M | 123.00M | -114.70M | |||
| OPERATING CASH FLOW | 276.40M | 254.40M | 325.30M | 352.20M | 205.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -50.96M | -38.20M | -44.90M | -44.30M | -51.70M | |||
| Other Investing Activity | -372.63M | -227.40M | -51.90M | -199.20M | 78.80M | |||
| INVESTING CASH FLOW | -423.58M | -265.60M | -96.90M | -243.50M | 27.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 247.00M | 94.00M | -85.50M | -15.50M | -148.50M | |||
| Stock Issued/Repurchased | -47.47M | 10.30M | -83.80M | 21.90M | 20.90M | |||
| Dividend Paid | -50.41M | -50.30M | -50.20M | -49.60M | -48.90M | |||
| Other Financing Activity | -32.40M | -31.40M | -23.40M | -19.30M | -7.30M | |||
| FINANCING CASH FLOW | 116.71M | 22.60M | -242.90M | -62.60M | -183.80M | |||
| Exchange Rate Effect | -4.07M | -3.40M | -12.10M | 6.40M | -2.80M | |||
| CHANGE IN CASH | -34.54M | 8.00M | -26.60M | 52.50M | 45.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 276.40M | 254.40M | 325.30M | 352.20M | 205.20M | |||
| Capital Expenditure | -50.96M | -38.20M | -44.90M | -44.30M | -51.70M | |||
| FREE CASH FLOW | 225.44M | 216.20M | 280.40M | 307.90M | 153.50M | |||
All data in USD